Skip to main content
SpringerLink
Log in

Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action

  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The interaction of retinoids and flavonoids with phospholipases A2 (PLA2) was studied to assess the mechanism of inhibition. Retinoids, such as retinal, retinol, retinoic acid and retinol acetate, and flavonoids, such as quercetin, rutin, morin and sciadopitysin, inhibit Ca2+-dependent PLA2 activity of human synovial fluid (HSF)in vitro in a dose-dependent fashion; ID50 s ranged from 2–8 μM. Retinal inhibited neutral active Ca2+-dependent PLA2s from human platelets, human plasma, human polymorphonuclear leukocytes andNaja mossambica mossambica venom in a dose-dependent manner while quercetin inhibits extracellular PLA2 activities of human plasma, HSF andN. m. mossambica venon in a dose-dependent manner but not PLA2 activity derived from human platelets and polymorphomonuclear leukocytes.

Inhibition of PLA2 activity by both flavonoid and retinoids were independent of Ca2+ or Na+. Increasing substrate concentration (9–144 nmols) relieved the inhibition of HSF-PLA2 activity by quercetin indicating probable interaction with the substrate. The inhibition by retinal is independent of substrate concentration suggesting that inhibition by retinal is probably due to direct interaction with the enzyme. both retinal and quercetin quenched the relative fluorescent intensity ofN. m. mossambica PLA2 and in a dose-dependent manner in the same concentration range at which they inhibitin vitro PLA2 activity. Retinal and quercetin shift the thermotropic phase transition of distearoylphosphatidylethanolamine (DSPE) liposomes. Both compounds broadened the transition peak, shifted theT m to lower temperature, and decreased enthalpy significantly. These findings indicate that inhibition of non-pancreatic human PLA2s by retinoids and flavonoids can be mediated by interaction with enzyme and/or substrate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C. Fiedler-Nagy, A. Georgiadis and J. W. Coffey,Effect of retinoids on arachidonic acid release and metabolism by rat peritoneal macrophages. Agents and Actions16, 620–621 (1985).

    Google Scholar 

  2. B. Havsteen,Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharm.32, 1141–1148 (1983).

    PubMed  Google Scholar 

  3. E. Middleton, Jr.,The flavonoids, Trends Pharmacol. Sci.5, 335–338 (1984).

    Google Scholar 

  4. C. Marcelo, R. Bartel and J. Fortune,Effect of retinoids and glucocorticoids on phospholipase A 2 and C mediated release of arachidonic acid by murine keratinocyte culture. Clin. Res.34, 766A (1986).

    Google Scholar 

  5. M. J. Alcaraz and J. R. S. Hoult,Effects of hypolactin-8-glucoside and related flavonoids on soybean lipoxygenase and snake venom phospholipase A 2.Arch. Int. Pharmacodyn. 278, 4–12 (1985).

    PubMed  Google Scholar 

  6. S. Rittenhouse-Simmons,Production of diglyceride from phosphatidylinositol in activated human platelets. J. Clin. Invest.63, 580–587 (1979).

    PubMed  Google Scholar 

  7. F. A. Kuehl, Jr. and R. W. Egan,Prostaglandins, arachidonic acid, and inflammation. Science210, 978–984 (1980).

    PubMed  Google Scholar 

  8. D. R. Robinson, D. P. Curran and P. J. Hamer,Prostaglandins and related compounds in inflammatory rheumatic diseases. InAdvances in Inflammation Research, vol. 3 (Eds. M. Ziff, G. P. Velo and S. Gorini) pp. 17–27, Raven Press, New York 1982.

    Google Scholar 

  9. R. J. Flower,The lipocortins and their role in controlling defence reactions. InAdvances in Prostaglandin, Thromboxane and Leukotriene Research, vol. 15. (Eds. O. Hayaishi and S. Yamamoto) pp. 201–203, Raven Press, New York 1985.

    Google Scholar 

  10. R. C. Franson, D. Eisen, R. Jesse and C. Lanni, Inhibition of highly purified mammalian phospholipase A2 by nonsteroidal anti-inflammatory agents, modulation by calcium ions. Biochem. J.186, 633–636 (1980).

    PubMed  Google Scholar 

  11. P. Vadas,The efficacy of anti-inflammatory agents with respect to extracellular phospholipase A 2 activity. Life sciences30, 155–162 (1982).

    PubMed  Google Scholar 

  12. A. A. Fawzy and R. C. Franson,Purification and characterization of human synovial fluid phospholipase A 2.Biophys. J. 49, 533 a (1986).

    Google Scholar 

  13. R. Jesse and R. C. Franson,Effects of highly purified platelet and granulocyte phospholipase A 2 on human platelet function. Clin. Res 27, 298 A (1979).

    Google Scholar 

  14. R. Jesse and R. Franson,Modulation of purified phospholipase A 2 activity from human platelets by calcium and indomethacin. Biochim. Biophys. Acta575, 467–470 (1979).

    PubMed  Google Scholar 

  15. F. Marki and R. Franson,Endogenous suppression of neutralactive and calcium-dependent phospholipase A 2 in human polymorphonuclear leukocytes. Biochim. Biophys. Acta879. 149–156 (1986).

    PubMed  Google Scholar 

  16. R. C. Franson, P. Patriarca, and P. Elsbach,Phospholipid metabolism by phagocytic cells. Phospholipase A 2 associated with rabbit polymorphonuclear leukocte granules. J. Lipid Res.15, 380–388 (1974).

    PubMed  Google Scholar 

  17. M. M. Bradford,A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.72, 248–254 (1976).

    PubMed  Google Scholar 

  18. B. S. Vishwanath, R. M. Kini and T. V. Gowda,Characterization of three edema-inducing phospholipase A 2 from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon25, 501–515 (1987).

    PubMed  Google Scholar 

  19. T. P. Lee, M. L. Matteliano and E. middleton, Jr.,Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism. Life Sciences31, 2765–2774 (1982).

    PubMed  Google Scholar 

  20. M. F. Roberts, R. A. Deems, T. C. Mincey, and E. A. Dennis,Chemical modification of the histidine residue in phospholipase A 2 (Naja naja naja). A case of half-site reactivity. J. Biol. Chem.252, 2405–2411 (1977).

    PubMed  Google Scholar 

  21. E. Vallee, J. Gougat, J. Navarro and J. F. Delahayes,Antiinflammatory and platelet anti-aggregant activity of phospholipase A 2 inhibitors. J. Pharm. Pharmacol.31, 588–592 (1979).

    PubMed  Google Scholar 

  22. A. J. Seppala, N.-E. L. Saris and M. L. Gauffin,Inhibition of phospholipase A-induced swelling of mitochondria by local anesthetics and related agents. Biochem. Pharmacol.20, 305–313 (1971).

    PubMed  Google Scholar 

  23. F. F. Davidson, E. A. Dennis, M. Powell, and J. R. Glenney, Jr.,Inhibition of phospholipase A 2 by “Lipocortins” and calpactins. An effect of binding to substrate phospholipids. J. Biol. Chem.262, 1698–1705 (1987).

    PubMed  Google Scholar 

  24. C. A. Langsford, M. R. Albrecht, T. M. Phelps, W. Stillwell and S. R. Wassall,Biophysical studies of retinoidphospholipid interactions. Biophys. J.51, 239a (1987).

    Google Scholar 

  25. R. D. Klausner, A. M. Kleinfeld, R. L. Hoover and M. J. Karnovsky,Lipid domains in membranes. Evidence derived from structural perturbations induced by free fatty acids and lifetime heterogeneity analysis. J. Biol. Chem.255, 1286–1295 (1980).

    PubMed  Google Scholar 

  26. L. R. Ballou and W. Y. Cheung,Inhibition of human platelet phospholipase A 2 activity by unsaturated fatty acids. Proc. Natl. Acad. Sci. USA82, 371–375 (1985).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biophysics, Medical College of Virginia, PO Box 614, Virginia, USA

    A. A. Fawzy, B. S. Vishwanath & R. C. Franson

  2. Commonwealth University, 23298-0614, Richmond, VA, USA

    A. A. Fawzy, B. S. Vishwanath & R. C. Franson

Authors
  1. A. A. Fawzy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. S. Vishwanath
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. C. Franson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fawzy, A.A., Vishwanath, B.S. & Franson, R.C. Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Agents and Actions 25, 394–400 (1988). https://doi.org/10.1007/BF01965048

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01965048

Keywords

Search

Navigation